The platform, described in a new paper in the journal ACS Infectious Diseases, could help to address the ongoing antibiotic resistance crisis, say the scientists. They modified and then tested red blood cells as a carrier for one of the world's only remaining resistance-proof antibiotics: Polymyxin B (PmB), widely considered a treatment of last resort due to its toxicity and harmful side effects, which include kidney damage.
Imphal (Manipur) [India], February 16 (ANI): As elections approach, Imphal's iconic all-women market, popularly known as Nupi Keithel or Ima Market, bears an indifferent, disillusioned look.
\
\
\
\
